Levcromakalim

CAS No. 94535-50-9

Levcromakalim( (-)-Cromakalim | BRL 38227 )

Catalog No. M24993 CAS No. 94535-50-9

Levcromakalim is an activator of the ATP-sensitive K+ channel.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 106 In Stock
2MG 67 In Stock
5MG 96 In Stock
10MG 145 In Stock
25MG 335 In Stock
50MG 488 In Stock
100MG 706 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Levcromakalim
  • Note
    Research use only, not for human use.
  • Brief Description
    Levcromakalim is an activator of the ATP-sensitive K+ channel.
  • Description
    Levcromakalim is an activator of the ATP-sensitive K+ channel.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (-)-Cromakalim | BRL 38227
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    ATP-sensitive potassium (KATP) channels
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    94535-50-9
  • Formula Weight
    286.33
  • Molecular Formula
    C16H18N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:50 mg/mL (174.62 mM);Water:Insoluble
  • SMILES
    CC(O1)(C)[C@@H](O)[C@H](N2CCCC2=O)C3=C1C=CC(C#N)=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Matsumoto T, et al. Tunicamycin-Induced Alterations in the Vasorelaxant Response in Organ-Cultured Superior Mesenteric Arteries of Rats. Biol Pharm Bull. 2016;39(9):1475-81.
molnova catalog
related products
  • JNJ 303

    JNJ 303 is a potent blocker of IKs (IC50 : 64 nM).

  • Doxapram

    Doxapram (Dopram) is a respiratory stimulant that inhibits TASK-1, TASK-3, and TASK-1/TASK-3 heterodimer channels and is used to study ventilatory failure caused by apnea of ??prematurity and exacerbation of chronic obstructive pulmonary disease.

  • NS6180

    NS6180 is a novel potent and selective KCa3.1 channel inhibitor(IC50= 9 nM) prevents T-cell activation and inflammation.